A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma
Clinical trial NCT02639182 · COMPLETED
Trial details
- NCT number
- NCT02639182
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-03
- Primary completion
- 2020-10-02
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.